We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$13.8M
Cap. Flow
-$371K
Cap. Flow %
-0.14%
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
11
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$930K
2
UL icon
Unilever
UL
+$381K
3
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$367K
4
DXCM icon
DexCom
DXCM
+$322K
5
FND icon
Floor & Decor
FND
+$290K

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$487K
2
VZ icon
Verizon
VZ
+$317K
3
SPLK
Splunk Inc
SPLK
+$314K
4
NVS icon
Novartis
NVS
+$292K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$231K

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 8.06%
3 Financials 7.83%
4 Consumer Discretionary 6.21%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
26
Mettler-Toledo International
MTD
$26.8B
$1.48M 0.56%
1,071
– –
PAYX icon
27
Paychex
PAYX
$40.4B
$1.47M 0.55%
13,667
– –
BBVA icon
28
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$1.43M 0.54%
230,332
– –
BLK icon
29
Blackrock
BLK
$164B
$1.41M 0.53%
1,612
– –
CRL icon
30
Charles River Laboratories
CRL
$10.9B
$1.41M 0.53%
3,806
– –
AMP icon
31
Ameriprise Financial
AMP
$46.8B
$1.38M 0.52%
5,551
– –
HON icon
32
Honeywell
HON
$77B
$1.37M 0.52%
6,637
– –
DFS
33
DELISTED
Discover Financial Services
DFS
$1.34M 0.51%
11,325
– –
SHOP icon
34
Shopify
SHOP
$148B
$1.32M 0.5%
9,050
– –
NVDA icon
35
NVIDIA
NVDA
$5.01T
$1.29M 0.49%
64,480
– –
HDB icon
36
HDFC Bank
HDB
$119B
$1.27M 0.48%
34,804
-2,160
-6% -$79.1K
UNH icon
37
UnitedHealth
UNH
$382B
$1.24M 0.47%
3,097
– –
ABBV icon
38
AbbVie
ABBV
$458B
$1.24M 0.47%
10,993
– –
UNP icon
39
Union Pacific
UNP
$182B
$1.23M 0.46%
5,585
– –
BCS icon
40
Barclays
BCS
$94.1B
$1.22M 0.46%
126,651
– –
USB icon
41
US Bancorp
USB
$99.6B
$1.22M 0.46%
21,381
– –
ALC icon
42
Alcon
ALC
$33.1B
$1.21M 0.46%
17,213
– –
ADBE icon
43
Adobe
ADBE
$89.5B
$1.16M 0.44%
1,975
– –
TTE icon
44
TotalEnergies
TTE
$193B
$1.14M 0.43%
25,077
– –
SNPS icon
45
Synopsys
SNPS
$71.5B
$1.1M 0.42%
4,006
– –
LULU icon
46
lululemon athletica
LULU
$13B
$1.07M 0.41%
2,945
– –
CCI icon
47
Crown Castle
CCI
$32.7B
$1.06M 0.4%
5,416
– –
SNY icon
48
Sanofi
SNY
$104B
$1.05M 0.4%
19,873
– –
ZTS icon
49
Zoetis
ZTS
$31.6B
$1.02M 0.38%
5,460
– –
NVS icon
50
Novartis
NVS
$295B
$1.01M 0.38%
11,106
-3,282
-23% -$292K
1
2
3 4 5

Similar funds

SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
YCG
Yeomans Consulting Group Marietta, Georgia $341M AUM 22.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
OFS
Oldfather Financial Services Kearney, Nebraska $336M AUM 15.03% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
PPH
Pure Portfolios Holdings Lake Oswego, Oregon $332M AUM 20.54% 1-Year Est. Return
TPW
Transatlantique Private Wealth New York $319M AUM 22.93% 1-Year Est. Return

Covenant Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Partners held 208 positions worth $265M, up 5.5% from $251M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q2 2021 filing shows 7 new, 11 increased, 28 reduced and 7 closed positions. Its largest new stake was Unilever: 5,724 shares worth $377K. The largest sale was Takeda Pharmaceutical, an estimated $487K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q2 2021 buy was Unilever: 5,724 shares worth $377K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q2 2021, an estimated $930K increase.
  • Covenant Partners's biggest Q2 2021 reduction was Takeda Pharmaceutical, cutting an estimated $487K.
  • Covenant Partners fully exited BioMarin Pharmaceuticals in Q2 2021, selling an estimated $231K.
  • Covenant Partners's ten largest holdings make up 49% of its $265M portfolio in Q2 2021.
  • Covenant Partners opened 7 new positions and closed 7 in Q2 2021.
  • Covenant Partners's portfolio value rose 5.5% quarter-over-quarter to $265M.

Based on Covenant Partners's 13F filing for Q2 2021, filed 2 Aug 2021.